2007 JASN IMPACT FACTOR 7.111	HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP
advanced	CURRENT ISSUE	ARCHIVES	JASN Express	ONLINE SUBMISSION

This Article Full Text Full Text (PDF) All Versions of this Article: ASN.2004070593v1 16/4/1061    most recent Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Troyanov, S. Search for Related Content PubMed PubMed Citation Articles by Troyanov, S.

Focal and Segmental Glomerulosclerosis: Definition and Relevance of a Partial Remission

Department of Nephrology, Toronto General Hospital, University Health Network, Toronto, Ontario, Canada

Address correspondence to: Dr. Daniel C. Cattran, University Health Network, Toronto General Hospital, NCSB 11-1256, 585 University Avenue, Toronto, Ontario M5G 2N2, Canada. Phone: 416-340-4187; Fax: 416-340-3714; E-mail: daniel.cattran{at}uhn.on.ca

Received for publication July 23, 2004. Accepted for publication November 18, 2004.

Focal and segmental glomerulosclerosis (FSGS) is one of the most common primary glomerular diseases to terminate in ESRD. A complete remission (CR) confers an excellent long-term prognosis, but the quantitative benefits of partial remissions (PR) have not been defined. This study evaluated the rate of renal function decline (slope of creatinine clearance) and renal survival in nephrotic FSGS patients with CR, PR, or no remission. It also examined relapse rate from remission and its impact on outcome. Multivariate analysis included clinical and laboratory data at presentation and over follow-up, BP control, the agents used, and immunosuppressive therapy. The study cohort was 281 nephrotic FSGS patients who had a minimum of 12 mo of observation and were identified from the Toronto Glomerulonephritis Registry. Over a median follow-up of 65 mo, 55 experienced a CR, 117 had a PR, and 109 had no remission. A PR was independently predictive of slope and survival from renal failure by multivariate analysis (adjusted time-dependent hazard ratio, 0.48; 95% confidence interval, 0.24 to 0.96; P = 0.04). Immunosuppression with high-dose prednisone was associated with a higher rate of PR and CR. Relapse from PR was frequent (56%) and associated with a more rapid rate of renal function decline and worse renal survival compared with relapse-free partial remitters. Only female gender and the nadir of proteinuria during remission were associated with a sustained remission. A PR in proteinuria and its maintenance are important therapeutic targets in FSGS, with implications for both slowing progression rate and improving renal survival.

This article has been cited by other articles:

				D. C. Cattran, H. N. Reich, H. J. Beanlands, J. A. Miller, J. W. Scholey, S. Troyanov, and for the Genes, Gender and Glomerulonephritis Group The impact of sex in primary glomerulonephritis Nephrol. Dial. Transplant., July 1, 2008; 23(7): 2247 - 2253. [Abstract] [Full Text] [PDF]

				O. Moranne, L. Watier, J. Rossert, B. Stengel, and The GN-Progress Study Group Primary glomerulonephritis: an update on renal survival and determinants of progression QJM, March 1, 2008; 101(3): 215 - 224. [Abstract] [Full Text] [PDF]

				Y. E. Chen, S. M. Korbet, R. S. Katz, M. M. Schwartz, E. J. Lewis, and for the Collaborative Study Group Value of a Complete or Partial Remission in Severe Lupus Nephritis Clin. J. Am. Soc. Nephrol., January 1, 2008; 3(1): 46 - 53. [Abstract] [Full Text] [PDF]

				H. N. Reich, S. Troyanov, J. W. Scholey, D. C. Cattran, and for the Toronto Glomerulonephritis Registry Remission of Proteinuria Improves Prognosis in IgA Nephropathy J. Am. Soc. Nephrol., December 1, 2007; 18(12): 3177 - 3183. [Abstract] [Full Text] [PDF]

				J. H. H. Ehrich, C. Geerlings, M. Zivicnjak, D. Franke, H. Geerlings, and J. Gellermann Steroid-resistant idiopathic childhood nephrosis: overdiagnosed and undertreated Nephrol. Dial. Transplant., August 1, 2007; 22(8): 2183 - 2193. [Abstract] [Full Text] [PDF]

				M. P. Winn, N. Daskalakis, R. F. Spurney, and J. P. Middleton Unexpected Role of TRPC6 Channel in Familial Nephrotic Syndrome: Does It Have Clinical Implications? J. Am. Soc. Nephrol., February 1, 2006; 17(2): 378 - 387. [Full Text] [PDF]

Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673